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Abstract
Background:  Triple-A syndrome (Allgrove syndrome) is an autosomal recessive disorder
characterized by adrenal insufficiency, alacrima, achalasia, and – occasionally – autonomic instability.
Mutations have been found in the AAAS gene on 12q13.
Case presentation: We present the case of a 12 year-old boy with classic systemic features of
triple-A syndrome and several prominent ophthalmic features, including: accommodative spasm,
dry eye, superficial punctate keratopathy, and pupillary hypersensitivity to dilute pilocarpine. MRI
showed small lacrimal glands bilaterally. DNA sequencing of PCR-amplified fragments from the 16
exons of the AAAS gene revealed compound heterozygosity for a new, out-of-frame 5-bp deletion
in exon 15, c1368-1372delGCTCA, and a previously-described nonsense mutation in exon 9,
c938C>T, R286X.
Conclusions: In addition to known ophthalmic manifestations, triple-A syndrome can present
with accommodative dysregulation and ocular signs of autonomic dysfunction.
Background
Triple-A syndrome (also known as Allgrove syndrome,
OMIM #231550) is a rare, autosomal recessive disease
characterized by alacrima, achalasia, ACTH-resistant adre-
nal insufficiency, autonomic dysfunction and neurode-
generation. [1,2] Ophthalmic manifestations include
alacrima and keratoconjunctivitis sicca, sometimes result-
ing in corneal melt; lacrimal gland atrophy; pupillary
abnormalities, including sluggish pupils, tonic pupils,
and hypersensitivity to dilute miotics; and optic atrophy.
[3-8] The phenotype in triple-A syndrome patients is
highly variable. [9] Mutations in the AAAS gene on chro-
mosome 12q13 have been described in several pedigrees
with triple-A syndrome (Table 1). [7,9-19] Molecular data
coupled with a detailed ophthalmic examination have not
be reported in the literature.
We report a case and a novel mutation in the AAAS gene
in a 12 year-old boy with triple-A syndrome who exhib-
ited evidence of accommodative spasms, in addition to
dry eye and pupillary hypersensitivity to 0.125%
pilocarpine.
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Case presentation
Clinical studies
The subject was examined at the National Eye Institute
and the National Institute of Child Health and Human
Development at the National Institutes of Health.
Informed parental consent and subject assent were
obtained prior to examination and molecular studies.
This study was performed in accordance with the Declara-
tion of Helsinki.
Pupillography was performed using a standard pupilom-
etry eye tracking system (ISAN Co, Burlington, Massachu-
setts). Pupil diameter was digitized at 60 Hz; binocular
150 ms stimuli delivered by green LEDs were used to elicit
the light reaction.
Genetic studies
Analysis of AAAS mutations was performed as follows:
Genomic DNA was isolated from whole blood following
standard procedures. Intronic primers (Invitrogen) were
appropriately chosen in order to sequence both splice
sites of each exon. Primer sequences are available upon
request. PCR products of each exon were run on agarose
gels, specific bands were cut and the DNA was isolated
following standard procedures. This DNA was sequences
in both directions using a Beckman Coulter CEQ8000 fol-
lowing the manufacturer's protocol.
History and examination
The subject was diagnosed with adrenocortical insuffi-
ciency with elevated plasma ACTH at age 1 after a
hypoglycemic seizure and was subsequently pharmaco-
logically supplemented with glucocorticoids. Mineraloco-
rticoid supplementation was initially instituted, but was
Table 1: Reported mutations in the AAAS gene in subjects with triple A syndrome. The numbering of nucleotides corresponds to the 
conventions of Dunnen and Antonarakis. [26] The most commonly-reported mutation is IVS 14+1G>A.
Position Protein cDNA Mutation References
IVS 4 IVS 4-2A>G Tullio-Pelet et al. (2000)
Ex 9 R312X 934C>T Tullio-Pelet et al. (2000)
Ex10 S328fsX363 981_982insT Tullio-Pelet et al. (2000)
IVS 14 IVS 14+1G>A Tullio-Pelet et al. (2000), Sandrini et al. (2001); Reshmi-Skarja et al (2003); 
Roubergue A et al (2004)
Ex 16 R478X 1432C>T Tullio-Pelet et al. (2000); Yuksel et al. (2004)
Ex 1 Q15K 43C>A Handschug et al. (2001), Sandrini et al. (2001), Houlden et al. (2002); Prpic et 
al. (2003)
Ex 2 W84X 251G>A Handschug et al. (2001)
Ex 6 H160R 479A>G Handschug et al. (2001)
Ex 6 F157fsX171 470_471delTT Handschug et al. (2001)
Ex 8 S263P 787T>C Handschug et al. (2001), Houlden et al. (2002); Prpic et al. (2003)
Ex 15 S463fsX549 1389delC Handschug et al. (2001)
Ex 9 R286X 856C>T Handschug et al. (2001), this report
Ex 11 R342X 1024C>T Handschug et al. (2001)
Ex 9 W295X 884G>A Schmittmann-Ohters (2001)
IVS 11 IVS 11+1G>A Sandrini et al. (2001)
Ex 16 R478X 1432C>T Goizet et al. (2002), Yuksel et al. (2004)
Ex 8 Q237X 709C>T Katsumata et al. (2002)
Ex 2 I70fsX92 210delC Houlden et al. (2002)
Ex 7 R230X 678C>T Houlden et al. (2002), Reshmi-Skarja et al. (2003)
Ex 10 V313A 1238T>C Houlden et al. (2002)
Ex 11 L356fsX362 1066-1067delCT Houlden et al. (2002)
Ex 12 S382fsX413 1144-1147delTCTG Houlden et al. (2002)
Ex 12 D368fsX382 1104-1105insC Houlden et al. (2002)
Ex 13 397fxs27 1191insA Houlden et al. (2002)
Ex 16 W474X 1421G>A Houlden et al. (2002)
Ex 12 Q387X 1159C>T Prpic et al. (2003)
Ex 2 H71fsX92 211delC Reshmi-Skarja et al. (2003)
Ex 4 R119X 355C>T Reshmi-Skarja et al. (2003)
Ex 5 Q145X 433C>T Reshmi-Skarja et al. (2003)
IVS 5 IVS 5+3insT Reshmi-Skarja et al. (2003)
Ex 15 Q456X 1366C>T Reshmi-Skarja et al. (2003)
Ex 15 X492 1368-1372delGCTCA this reportBMC Ophthalmology 2004, 4:7 http://www.biomedcentral.com/1471-2415/4/7
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subsequently discontinued. He cried without tears since
birth. At age 2 he developed achalasia, which was treated
successfully with surgery. The diagnosis of triple-A syn-
drome was made at age 4. Pregnancy and birth history
were unremarkable. The subject was previously diagnosed
with accommodative esotropia and treated with hyper-
opic correction. The proband's parents and three siblings
did not have similar symptoms and were healthy. The par-
ents' grandparents were from the same town in Italy, but
there was no known consanguinity. The subject had
speech delay as a child and receives speech therapy. He is
currently enrolled in a normal 5th grade class with special
aids for English, social studies and math. Over the past
few years, he has developed ataxia. Review of systems was
notable for photophobia and dry mouth.
Physical examination was remarkable for a fissured, dry
tongue; palmar and plantar keratosis; +4 upper- and
lower-extremity reflexes; 3–4 beats of lower-extremity
clonus; a positive Babinski sign; and ataxic responses to
tandem gait and finger-to-nose testing. The subject did
not have orthostatic hypotension. Nerve conduction stud-
ies were not performed. An echocardiogram and an elec-
trocardiogram were normal. CT of the abdomen was
remarkable for little to no adrenal gland tissue. MRI of the
brain showed no abnormalities, but the main lacrimal
glands appeared small bilaterally (Figure 1).
Visual acuity with his current spectacles (+3.25+1.50 ×
120 OD, +3.25+1.50 × 100 OS) was 20/200 OD and 20/
150 OS. Manifest refraction of -0.25+1.00 × 120 OD and
+0.75 + 1.25 × 60 OS improved acuity to 20/50 and 20/
70, respectively. Near vision at 14 inches was J7 OD and
J3 OS. The subject had 400" of stereopsis on Titmus test-
ing and had a red-green color deficiency (saw 3 of 15 Ishi-
hara plates with each eye). Ocular motility was full and
without nystagmus. Alternate cover testing with his cur-
rent spectacles showed a 16–18 PD esotropia (ET) at 1/3
m and an 8 PD ET at 6 m. When allowed to wear a +3.00
D over his current refraction for several minutes, his ET
decreased at near to 2–3 PD. Near point of accommoda-
tion was 11 cm OD and 9 cm OS. The patient had a some-
what variable, 35–40 ET at distance and near without
correction. Clinically, his pupils were 5 mm OD and 5.5
mm OS and were somewhat sluggishly reactive to light.
However, his light reaction to LED stimuli recorded with
pupillography showed a relatively normal wave form.
There was no afferent pupillary defect and constriction at
near was not tested. The right pupil was tested with
0.125% pilocarpine and showed constriction to 2.5 mm
in approximately 10 minutes. Schirmer testing results
with anesthesia were 6 mmOD and 12 mmOS. Slit lamp
examination was remarkable for trace injection, a
decreased tear lake, and mild, bilateral superficial punc-
tate keratopathy. Intraocular pressures were 11 mm Hg
OD and 15 mmHg OS. His optic nerves, vessels, maculae,
and retinal peripheries were normal on dilated examina-
tion. Cycloplegic refraction was +2.75 + 1.75 × 70 OD and
+3.00 + 1.00 × 120. With this refraction, the subject could
read 20/50 OD and 20/70 OS. After approximately 1 year
of spectacle correction and amblyopia treatment, the sub-
ject's best-corrected vision improved to 20/30 OD and 20/
40 OS. His stereopsis improved to 100 seconds of arc and
his performance on Ishihara color-plate testing was stable.
Molecular testing
After informed consent, 5 cc of blood was drawn for
research purposes. Sequencing of all 16 coding exons of
the AAAS gene revealed compound heterozygosity for two
mutations, both of which are predicted to premature
stops in translation. In exon 9, the nonsense mutation
leads to a shortened protein of 286, instead of 546, amino
acids. In exon 15, and out-of-frame 5-bp deletion, c1368-
1372delGCTCA, leads to a premature stop codon and a
shortened protein of 492 amino acids (Figure 2.) Because
both sequence changes are expected to result in premature
truncation of the AAAS protein, they are likely pathologi-
cal. This sequence alterations were  not present in 100
control chromosomes from unaffected individuals.
Discussion
We present the case of an 12 year-old boy with classic tri-
ple-A syndrome who is a compound heterozygote for
mutations in the AAAS gene. One mutation (R286X) has
been previously reported and the other (c1368-
1372delGCTCA) is novel. [11] The ophthalmic features
consistent with the diagnosis of triple-A syndrome in this
patient included: decreased tear production with a history
of no spontaneous tearing; superficial punctate keratopa-
thy; and increased pupillary sensitivity to 0.125% pilo-
carpine. In addition, the subject also appeared to
inappropriately accommodate, as comparison of the
uncyclopleged manifest refraction and the cycloplegic
refraction suggested. This is not likely to be simply mani-
festation of his accommodative esotropia, per se. Although
his esotropia improved with hyperopic correction, his
vision did not until accommodation was pharmacologi-
cally blocked or until a compensatory refraction was
given.
Accommodation results from contraction of the ciliary
muscles, relaxation of the lens zonules, and an increase in
the effective refracting power of the lens. This process is
mediated via cholinergic, parasympathetic motor fibers.
Patients with triple-A syndrome often manifest signs of
autonomic dysregulation, including decreased lacrima-
tion, pupillary abnormalities, orthostatic hypotension,
sexual impotence, disturbances of heart rate, and abnor-
mal reactions to intradermal histamine. [5,7] We hypoth-
esize that the refractive difficulties experienced by ourBMC Ophthalmology 2004, 4:7 http://www.biomedcentral.com/1471-2415/4/7
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subject are related to autonomic dysfunction. Alterna-
tively, because patients with triple-A syndrome have a
neurodegenerative process that can affect cranial nerves,
[14] the observed dysregulation may be due to central
causes.
The decreased best-corrected visual acuity in this boy may
have been due to superficial punctate keratopathy and/or
amblyopia. Patients with triple-A syndrome sometimes
develop optic atrophy. [7] Although our patient did not
have clinical evidence of optic nerve dysfunction, we can-
not rule out a subtle process that produced a moderate
MRI of the brain of 12 year-old boy with triple-A syndrome showing hypoplastic lacrimal glands (yellow arrows.) Figure 1
MRI of the brain of 12 year-old boy with triple-A syndrome showing hypoplastic lacrimal glands (yellow arrows.)BMC Ophthalmology 2004, 4:7 http://www.biomedcentral.com/1471-2415/4/7
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degree of visual impairment, despite the normal appear-
ance of both the optic nerves and brain imaging. Simi-
larly, it is possible that photoreceptor dysfunction in the
retina – while never reported in triple-A syndrome – could
explain some of the decreased best-corrected visual acuity
and his red-green color deficiency. The patient was not
available for follow-up testing with an electroretinogram,
but his improvement with spectacle correction and
amblyopia treatment over a year time argues against a pro-
gressive photoreceptor degeneration.
Lacrimation – both reflex and basal – is under parasympa-
thetic control, as is pupillary miosis. [20-22] Autonomic
dysfunction at the level of the lacrimal glands and the
pupil presumably explain the abnormalities seen in this
condition. Mullaney et al. noted small lacrimal glands on
orbital imaging and a reduced number of serous-secreting
cells on lacrimal gland biopsy of three patients with triple-
A syndrome. [4] The hypersensitivity to dilute pilocarpine
is likely due to up-regulation of post-synaptic muscarinic
receptors on the iris sphincter. Frequent ocular lubrication
was recommended to this subject.
The AAAS gene contains 16 exons and codes for a 546
amino acid protein called ALADIN. [10] ALADIN does
not have major homology to any known proteins, but
Compound heterozygous mutations in AAAS gene in subject with triple-A syndrome Figure 2
Compound heterozygous mutations in AAAS gene in subject with triple-A syndrome. The subject has a novel, five base-pair 
deletion in exon 15 (A, deletion boxed in control panel) predicted to cause a frameshift and a premature truncation of the Ala-
din protein. He also had a cytosine to thymidine mutation (B) in exon 9, predicted to cause a premature stop of protein 
translation.BMC Ophthalmology 2004, 4:7 http://www.biomedcentral.com/1471-2415/4/7
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contains four WD motifs. WD proteins are a functionally
diverse family whose members are involved in processes
such as cell division, cell-fate determination, transcrip-
tion, transmembrane signaling and intracellular traffick-
ing. [23] Proteomic analysis of the mammalian nuclear
pore complex (NPC) has shown that ALADIN is part of
this structure, which is critical for communication
between the nucleus and the cytoplasm of cells. [24]
When mutated, ALADIN localizes to the cytoplasm, rather
than the NPC. [25] However, cells from a subject with tri-
ple-A syndrome showed morphologically normal NPCs.
These findings suggest that ALADIN is likely critical for
nuclear pore function, rather than NPC structure. ALADIN
may therefore be critical for the development of mainte-
nance of the cell types affected in triple-A syndrome.
Reshmi-Skarja et al. recently described chromosome and/
or chromatid breaks, whole chromosome arm deletions,
and marker chromosomes involving 9q12, a heterochro-
matic region know to be a fragile site, in subjects with tri-
ple-A syndrome [17].
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